Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Of Sunitinib Malate Single Agent For The Treatment Of Women With Advanced Breast Cancer

NCT00471276 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00471276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00471276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Of Sunitinib Malate Single Agent For The Treatment Of Women With Advanced Breast Cancer
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2007
Completion date
June 30, 2010
Enrollment
83 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms